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Background
Chronic obstructive pulmonary disease (COPD) is charac-
terized by irreversible airflow limitation, abnormal perma-
nent distal air-space enlargement and emphysema in the
lungs. Increased oxidative burden in COPD is because of
both directly a result of smoking and indirectly by the
release of increasing amount of ROS from airways leuko-
cytes. The CYP1A1 gene modifies the phase I enzyme aryl
hydrocarbon hydroxylase (AHH) belonging to the cyto-
chrome P450 system that plays a major role in the meta-
bolism of exogenous toxins generated by cigarette smoke
[1]. The aim of the present study is to assess the role of
CYP1A1 gene polymorphism and to measure the plasma
nitric oxide levels in the etiology of COPD in South Indian
Population from Andhra Pradesh.
Materials and methods
A cohort of 250 clinically and spirometrically confirmed
COPD patients referred to Government Chest Hospital,
Hyderabad and an equal member of age and sex matched
control subjects were included in the present study.
Genotyping of CYP1A1 gene polymorphism was done by
PCR – RFLP method followed by agarose gel electro-
phoresis. The plasma nitrite levels were estimated by
spectrophotometric method. Appropriate statistical
methods were applied to test for the significance of the
results.
Results
Genotypic distribution of CYP1A1 gene polymorphism
revealed 36.8% of TT, 50.8% of TC and 12.4% of CC
genotypes in COPD patients and 44.8% of TT, 48.4% of
TC and 6.8% of CC in control subjects (Figure 1). There
is an increased frequency of CC genotype and C allele
in the COPD patients compared to control subjects
(X2 = 4.51; p=0.03; OR=1.94; 95% CI = (1.044-3.605)
and (X2=5.12; p=0.02; OR=1.35; 95% CI=(1.041-1.758).
(Table 1). The study carried out from North Indian
population have shown that CYP1A1,-3801 polymorph-
ism was significantly associated with COPD [2]. The
mean levels of plasma nitrite levels were also found to
significantly elevated in COPD patients (2.715 ± 1.552)
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Figure 1 Agarose Gel Electrophoresis showing the Amplification of
340 bp, 200 bp and 140 bp product After Restriction enzyme
digestion by (MspI).
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in comparison with their respective controls (1.123 ±
0.699) (p<0.001) (t value = 2.6449).
Conclusions
The present study indicates the association of CYP1A1
gene polymorphism and plasma nitric oxide levels in the
etiology of COPD patients of South Indian population
from Andhra Pradesh.
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Table 1 Comparison of genotypes and alleles of CYPA1-
3801 T /C in COPD and Controls
X2 p Value Odds Ratio 95% CI Genotype/Allele
TT Vs TC + CC 3.31 0.06 0.71(0.5015-1.026)
TC Vs TT+CC 0.28 0.59 1.10(0.7752-1.563)
CCVs TC + TT 4.51 0.03 1.94(1.044-3.605)
C Vs T 5.12 0.02 1.35(1.041-1.758)
T Vs C 5.12 0.02 0.73(0.56-0.960)
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